1-5 of 5
Catherine Rioufol
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epstein-Barr Virus (EBV) Reactivation, Its Treatment with Rituximab and Their Impact on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Florence Ranchon, PharmD, Sandrine Leroy, MD, Fiorenza Barraco, MD, Xavier Thomas, MD PhD, Marie Balsat, MD, Caroline Lejeune, MD, Sophie Ducastelle, MD, Bruno Lina, MD PhD, Florence Morfin, MD, Myriam Renault, CRA, Florence Ader, MD, Catherine Rioufol, PharmD, Helene Labussiere, MD, Franck-Emmanuel Nicolini, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3695.
https://doi.org/10.1182/blood.V128.22.3695.3695
Published: 2016
Journal Articles

Tacrolimus Given As an Alternative to Cyclosporin after Allogeneic HSCT in Case of Renal Impairment: A Prospective Pilot Study

Marie Y Detrait, MD, Stéphane Morisset, Stat, Anne Beatrice Notarantonio, Pochon Cecile, Sabine Cohen, Catherine Rioufol, PharmD, Gabrielle Roth Guepin, Maud D'Aveni, Adele Dhuyser, Sylvie Tarillon, Chapel Valerie, Marie t Rubio, MDPhD, Barraco Fiorenza, Mauricette Michallet, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5749.
https://doi.org/10.1182/blood.V128.22.5749.5749
Published: 2016
Journal Articles

Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot Study

Marie Y. Detrait, MD, Stephane Morisset, Sabine Cohen, Monique Manchon, Verane Schwiertz, Florence Ranchon, Nicolas Vantard, Caroline Serrier, MD, Adrien Quintela, Christiane Cazac, Carole Hospital, Valerie Chapel, Sothiny Sar, Catherine Rioufol, Mauricette Michallet, MD, PhD, Fiorenza Barraco, MD
Journal: Blood
Blood (2013) 122 (21): 4549.
https://doi.org/10.1182/blood.V122.21.4549.4549
Published: 2013
Journal Articles

Flamsa-RIC Sequential Regimen in High Risk CR1 AML Patients: Preliminary Results From a Pilot Study

Marie Y. Detrait, MD, Mohamad Sobh, Pharm.M., Xavier Thomas, MD, Verane Schwiertz, Florence Ranchon, Sandrine Hayette, Isabelle Tigaud, MD, Franck E. Nicolini, MD, PhD, Fiorenza Barraco, MD, Sophie Ducastelle, MD, Youcef Chelghoum, MD, Hélène Labussière-Wallet, MD, Adrien Quintela, Nathalie Tedone, CRA, Sothiny Sar, Valérie Chapelle, Stéphane Morisset, Stat., Jean-Pierre Magaud, Catherine Rioufol, PharmD, Mauricette Michallet, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4549.
https://doi.org/10.1182/blood.V120.21.4549.4549
Published: 2012
Journal Articles

Azacitidine Use in MDS and AML Patients: Best Selection for Better Results

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm. M., Stéphane Morisset, Stat., Carine Champigneulle, CRA, Florence Ranchon, Marie Y. Detrait, MD, Hélène Labussière-Wallet, MD, Sophie Ducastelle, MD, Franck E. Nicolini, MD, PhD, Youcef Chelghoum, MD, Xavier Thomas, MD, Caroline Le jeune, MD, Eric Wattel, MD, PhD, Catherine Rioufol, PharmD, Fiorenza Barraco, MD
Journal: Blood
Blood (2012) 120 (21): 5070.
https://doi.org/10.1182/blood.V120.21.5070.5070
Published: 2012